FUJIFILM Biotechnologies’ Galaxy project is redefining how large-scale biopharmaceutical manufacturing facilities are designed, built, and deployed. Recognized with an Honorable Mention in the 2026 ISPE Facility of the Year Awards (FOYA), the facility exemplifies how digital replication, modular construction, and Pharma 4.0™ technologies can accelerate the delivery of critical manufacturing...
Hepalink Pharmaceutical Group Co., Ltd. has earned recognition in the 2026 ISPE Facility of the Year Awards (FOYA) Innovation – Novel Technology category for its groundbreaking Shenzhen Hepalink Pingshan New Pre-filled Syringe Manufacturing Facility. The award recognizes facilities that demonstrate the innovative application of manufacturing technologies, facility design, and engineering...
AstraZeneca’s Commercial Cell Therapy Facility in Rockville, Maryland is setting a new benchmark for how pharmaceutical manufacturers can deliver lifesaving therapies while simultaneously advancing sustainability and operational excellence. Recognized as the 2026 ISPE Facility of the Year Awards (FOYA) Social Impact – Unmet Medical Needs Category Winner, the facility demonstrates how...
Eli Lilly and Company’s Lilly Concord manufacturing facility is redefining what is possible in pharmaceutical project delivery. Recognized with the 2026 ISPE Facility of the Year Awards (FOYA) Operations – Project Execution Category Award, the North Carolina site demonstrates how innovative execution strategies, advanced digital technologies, and disciplined governance can dramatically...
As antibody-drug conjugates (ADCs) continue to transform cancer treatment, manufacturers face increasing pressure to deliver these highly complex therapies faster, more safely, and with greater reliability. Yet one of the industry's most persistent challenges remains the fragmented supply chain traditionally required to produce ADCs.
